Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

Recruiting now

Conditions studied: Ovarian Stimulation

In brief

This study examines if monitoring serum Follicle Stimulation Hormone (FSH) levels can predict oocyte yield and progesterone levels, considering factors like age, baseline FSH, Antral Mullerian Hormone (AMH), antral follicle count, body weight, kidney function, and urinary FSH. The aim is to find a minimum FSH level that ensures optimal ovarian response and enables tailored FSH dosages for better outcomes.

Key facts

Study ID

NCT06572930

Run by

ART Fertility Clinics LLC

People needed

150

Starts

2024-12-16

Expected to finish

2026-12-01

Last updated by the study team

2026-06-25

Who can join

Age: 18 and older, up to 39. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• regular 21 - 35 days cycles
• BMI between 19 - 30 kg/m2
• serum AMH level between 1.5 to 3 ng/ml
• a total antral follicle count between 10 to 24
• endogenous early follicular phase serum FSH level <10 IU/L
• normal glomerular filtration rate

You may not qualify if…

• hypogonadotropic hypogonadism
• history of ovarian surgery
• permanent ovarian cysts of any form
• older than 39 years
• abnormal thyroid stimulating hormone (TSH)
• renal disease
• elevated prolactin levels
• intake of oral contraceptives 3 months before stimulation start and estradiol pretreatment will be excluded

Where it is running

• ART Fertility Clinics — Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.